Agile Therapeutics Inc (AGRX) stock has fallen -87.78% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives AGRX stock a score of 33 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 2. AGRX's rank also includes a long-term technical score of 3.
AGRX has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on AGRX!
Agile Therapeutics Inc (AGRX) stock has risen 6.94% while the S&P 500 is up 0.42% as of 10:27 AM on Friday, Sep 22. AGRX is up $0.12 from the previous closing price of $1.73 on volume of 54,604 shares. Over the past year the S&P 500 has gained 15.71% while AGRX has fallen -87.78%. AGRX earned $5.93 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 0.31.
Click Here to get the full Stock Report for Agile Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
